AstraZeneca PLC ADR

25 jul 2024, 09:17 UTC

AstraZeneca Raises Guidance After Results Beat Market Expectations -- Update

25 jul 2024, 06:48 UTC

AstraZeneca Raises Guidance After Revenue, Earnings Beat Market Expectations

12 jul 2024, 19:57 UTC

Instil Bio Shares Surge Following Rental Agreement with AstraZeneca

5 sept 2024, 13:00 UTC

China Detains AstraZeneca Employees Over Alleged Transport of Unapproved Drug -- WSJ

29 jul 2024, 10:30 UTC

Big Pharma Rallies and Moves Past Obesity -- Heard on the Street -- WSJ

25 jul 2024, 13:20 UTC

AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD

25 jul 2024, 09:21 UTC

AstraZeneca's Guidance Lift Is Conservative; Risks to Upside -- Market Talk

25 jul 2024, 07:05 UTC

AstraZeneca Guidance Raise Signals Portfolio Potential -- Market Talk

25 jul 2024, 06:06 UTC

AstraZeneca Increased Interim Dividend by 7c to $1.00

25 jul 2024, 06:04 UTC

AstraZeneca Had Seen Core EPS Grow by Low Double-Digit to Low Teens Percentage Range

25 jul 2024, 06:04 UTC

AstraZeneca Had Seen Total Revenue Grow by Low Double-Digit to Low Teens Percentage Range

25 jul 2024, 06:04 UTC

AstraZeneca Sees Core EPS Growth in 2024 by Mid Teens Percentage Range At Constant Currency

25 jul 2024, 06:04 UTC

AstraZeneca Sees Total Revenue Growth in 2024 by Mid Teens Percentage Range At Constant Currency

25 jul 2024, 06:03 UTC

AstraZeneca Raises 2024 View

25 jul 2024, 06:02 UTC

AstraZeneca 2Q Revenue Consensus Was $12.7B

25 jul 2024, 06:02 UTC

AstraZeneca 2Q Core EPS Consensus Was $1.95

25 jul 2024, 06:00 UTC

AstraZeneca PLC 2Q Adj EPS $1.98

25 jul 2024, 06:00 UTC

AstraZeneca PLC 2Q Pretax Pft $2.4B

25 jul 2024, 06:00 UTC

AstraZeneca PLC 2Q Rev $12.94B

25 jul 2024, 06:00 UTC

AstraZeneca PLC 2Q Oper Pft $2.75B

25 jul 2024, 06:00 UTC

AstraZeneca PLC 2Q Net Pft $1.93B

25 jul 2024, 06:00 UTC

AstraZeneca PLC 2Q EPS $1.24

15 jul 2024, 06:04 UTC

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

15 jul 2024, 06:04 UTC

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

15 jul 2024, 06:02 UTC

AstraZeneca: Acquisition Includes $800M Upfront at Deal Closing

15 jul 2024, 06:02 UTC

AstraZeneca: Amolyt Pharma's Total Consideration of Up to $1.05B

15 jul 2024, 06:01 UTC

AstraZeneca: Acquisition Bolsters Alexion Rare Disease Late-Stage Pipeline

15 jul 2024, 06:00 UTC

AstraZeneca Completes Acquisition of Amolyt Pharma

15 jul 2024, 06:00 UTC

AstraZeneca PLC Acquisition of Amolyt Pharma completed

15 jul 2024, 06:00 UTC

AstraZeneca PLC Acquisition of Amolyt Pharma completed